Rezultaty Documents, reports (1) e-Survey software platform eSurvey software platform Beta release of eSurvey platform including mobile app for Android and iOS platforms and Backend system for the management of users participant consents studies and associated data The release is for testing purposes The software will be available as opensource through GitHub Websites, patent fillings, videos etc. (1) Webiste available online details on data access Website available online Publikacje Peer reviewed articles (49) Accuracy of High-Risk HPV DNA PCR, P16(INK4a) Immunohistochemistry or the Combination of Both to Diagnose HPV-Driven Oropharyngeal Cancer Autorzy: Cindy Simoens, Tarik Gheit, Ruediger Ridder, Ivana Gorbaslieva, Dana Holzinger, Eric Lucas, Susanne Rehm, Peter Vermeulen, Martin Lammens, Olivier M. Vanderveken, Rekha Vijay Kumar, Nitin Gangane, Alessandro Caniglia, Fausto Maffini, Maria Belén Lloveras Rubio, Devasena Anantharaman, Susanna Chiocca, Paul Brennan, Madhavan Radhakrishna Pillai, Rengaswamy Sankaranarayanan, Johannes Bogers, Michael Opublikowane w: BMC Infectious Diseases, Issue 22, 2022, Page(s) 676, ISSN 1471-2334 Wydawca: BioMed Central DOI: 10.1186/s12879-022-07654-2 Pricing of HPV Tests in Italian Tender-Based Settings Autorzy: Federica Inturrisi and Johannes Berkhof Opublikowane w: Journal of Medical Economics, Issue 25(1), 2022, Page(s) 762–68, ISSN 1369-6998 Wydawca: P J B Publications Ltd. DOI: 10.1080/13696998.2022.2082777 Cervical Cancer Screening Using HPV Tests on Self-Samples: Attitudes and Preferences of Women Participating in the VALHUDES Study Autorzy: Hélène De Pauw, Gilbert Donders, Steven Weyers, Philippe De Sutter, Jean Doyen, Wiebren A. A. Tjalma, Davy Vanden Broeck, Eliana Peeters, Severien Van Keer, Alex Vorsters, and Marc Arbyn Opublikowane w: Archives of Public Health, Issue 79, 2021, Page(s) 155, ISSN 0778-7367 Wydawca: London BioMed Central DOI: 10.1186/s13690-021-00667-4 Increasing Global Accessibility to High-Level Treatments for Cervical Cancers Autorzy: Chargari, C., M. Arbyn, A. Leary, N. R. Abu-Rustum, P. Basu, F. Bray, S. Chopra, R. Nout, K. Tanderup, A. N. Viswanathan, C. Zacharopoulou, J. C. Soria, E. Deutsch, S. Gouy, and P. Morice Opublikowane w: Gynecologic Oncology, Issue 231–41, 2022, Page(s) 164(1), ISSN 0090-8258 Wydawca: Academic Press DOI: 10.1016/j.ygyno.2021.10.073 Can HPV Selfy Be Considered as a Clinically Validated HPV Test for Use in Cervical Cancer Screening? Autorzy: Marc Arbyn, Jesper Bonde, Kate Cushieri, and Mario Poljak Opublikowane w: Journal of Translational Medicine, Issue 20, 2022, Page(s) 422, ISSN 1479-5876 Wydawca: BioMed Central DOI: 10.1186/s12967-022-03627-w Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework Autorzy: Helle Pedersen, Ditte M. Ejegod, Wim Quint, Lan Xu, Marc Arbyn, and Jesper Bonde Opublikowane w: The Journal of Molecular Diagnostics, Issue JMD 24(4), 2022, Page(s) 365–73, ISSN 1525-1578 Wydawca: American Society for Investigative Pathology DOI: 10.1016/j.jmoldx.2021.12.009 Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence Autorzy: Marc Arbyn, Remila Rezhake, Susan Yuill, Karen Canfell Opublikowane w: British Journal of Cancer, Issue 122/11, 2020, Page(s) 1577-1579, ISSN 0007-0920 Wydawca: Nature Publishing Group DOI: 10.1038/s41416-020-0787-9 Risk of Cervical Precancer among HPV–Negative Women in the Netherlands and Its Association with Previous HPV and Cytology Results: A Follow-up Analysis of a Randomized Screening Study Autorzy: Federica Inturrisi, Lawrence Rozendaal, Nienke J. Veldhuijzen, Daniëlle A. M. Heideman, Chris J. L. M. Meijer, and Johannes Berkhof Opublikowane w: PLOS Medicine, Issue 19(10), 2022, Page(s) e1004115, ISSN 1549-1277 Wydawca: Public Library of Science DOI: 10.1371/journal.pmed.1004115 An International Consensus on the Essential and Desirable Criteria for an ‘Organized’ Cancer Screening Programme Autorzy: Li Zhang André L. Carvalho, Isabel Mosquera, Tianmeng Wen, Eric Lucas, Catherine Sauvaget, Richard Muwonge, Marc Arbyn, Elisabete Weiderpass, and Partha Basu Opublikowane w: BMC Medicine, Issue 20(1), 2022, Page(s) 101, ISSN 1741-7015 Wydawca: BioMed Central DOI: 10.1186/s12916-022-02291-7 Clinical Performance of the RealTime High Risk HPV Assay on Self-Collected Vaginal Samples within the VALHUDES Framework Autorzy: Ardashel Latsuzbaia, Davy Vanden Broeck, Severien Van Keer, Steven Weyers, Wiebren A. A. Tjalma, Jean Doyen, Gilbert Donders, Philippe De Sutter, Alex Vorsters, Eliana Peeters, and Marc Arbyn Opublikowane w: Microbiology Spectrum, Issue 10(5), 2022, Page(s) e01631-22, ISSN 2165-0497 Wydawca: ASM International DOI: 10.1128/spectrum.01631-22 HPV Testing of Self-Samples: Influence of Collection and Sample Handling Procedures on Clinical Accuracy to Detect Cervical Precancer Autorzy: Marc Arbyn, Ardashel Latsuzbaia, Philip E. Castle, Vikrant V. Sahasrabuddhe, and Davy Vanden Broeck Opublikowane w: The Lancet Regional Health – Europe, Issue 14, 2022, ISSN 2666-7762 Wydawca: Oxford: Elsevier Ltd. DOI: 10.1016/j.lanepe.2022.100332 Clinical Evaluation of P16INK4a Immunocytology in Cervical Cancer Screening: A Population-Based Cross-Sectional Study from Rural China Autorzy: Remila Rezhake, Yan Wang, Feng Chen, Shang-Ying Hu, Xun Zhang, Jian Cao, You-Lin Qiao, Fang-Hui Zhao, and Marc Arbyn Opublikowane w: Cancer Cytopathology, Issue 129(9), 2021, Page(s) 679–92, ISSN 1934-662X Wydawca: Wiley-Blackwell DOI: 10.1002/cncy.22428 Papilloplex HR-HPV Test Has Non-Inferior Clinical Performance for Detection of Human Papillomavirus Infection: Assessment Using the VALGENT Framework Autorzy: Ramya Bhatia, Elia Alcaniz Boada, Jesper Hansen Bonde, Wim G. V. Quint, Lan Xu, Ditte Moller Ejegod, Kate Cuschieri, and Marc Arbyn Opublikowane w: Journal of Clinical Pathology, Issue 2021-11-15, 2021, ISSN 0021-9746 Wydawca: BMJ Publishing Group DOI: 10.1136/jclinpath-2021-207864 Global Estimates of Expected and Preventable Cervical Cancers among Girls Born between 2005 and 2014: A Birth Cohort Analysis. Autorzy: Maxime Bonjour, Hadrien Charvat, Eduardo L. Franco, Marion Piñeros, Gary M. Clifford, Freddie Bray, and Iacopo Baussano Opublikowane w: The Lancet Public Health, Issue 6(7), 2021, Page(s) e510–2, ISSN 2468-2667 Wydawca: London: Elsevier Ltd. DOI: 10.1016/s2468-2667(21)00046-3 Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses Autorzy: Arroyo Mühr, Laila Sara, Carina Eklund, Camilla Lagheden, Tiina Eriksson, Ville N. Pimenoff, Penelope Gray, Matti Lehtinen, and Joakim Dillner Opublikowane w: The Journal of Infectious Diseases, Issue 226(7), 2022, Page(s) 1195–99, ISSN 0022-1899 Wydawca: University of Chicago Press DOI: 10.1093/infdis/jiac190 Global Estimates of Incidence and Mortality of Cervical Cancer in 2020: A Baseline Analysis of the WHO Global Cervical Cancer Elimination Initiative Autorzy: Deependra Singh, Jerome Vignat, Valentina Lorenzoni, Marzieh Eslahi, Ophira Ginsburg, Beatrice Lauby-Secretan, Marc Arbyn, Partha Basu, Freddie Bray, and Salvatore Vaccarella Opublikowane w: The Lancet Global Health, Issue 11(2), 2023, Page(s) e197–206, ISSN 2214-109X Wydawca: Elsevier BV DOI: 10.1016/s2214-109x(22)00501-0 Worldwide use of HPV self-sampling for cervical cancer screening. Autorzy: Serrano B, Ibáñez R, Robles C, Peremiquel-Trillas P, de Sanjosé S, Bruni L. Opublikowane w: Prev Med., Issue 154, 2022, Page(s) 106900., ISSN 0091-7435 Wydawca: Academic Press DOI: 10.1016/j.ypmed.2021.106900 Stratified Mucin-Producing Intraepithelial Lesion (SMILE) of the Uterine Cervix: High-Risk HPV Genotype Predominance and P40 Immunophenotype Autorzy: Strojan Fležar, Margareta, Neža Nedelko, Mario Poljak, Anja Oštrbenk Valenčak, and Helena Gutnik Opublikowane w: Cells, Issue 10(8), 2021, Page(s) 2039, ISSN 2073-4409 Wydawca: Basel MDPI AG 2012- DOI: 10.3390/cells10082039 Women with a Positive High-Risk Human Papillomavirus (HPV) Test Remain at Increased Risk of HPV Infection and Cervical Precancer ≥15 Years Later Autorzy: Federica Inturrisi, Johannes A. Bogaards, Albert G. Siebers, Chris J. L. M. Meijer, Daniëlle A. M. Heideman, and Johannes Berkhof Opublikowane w: Tumour Virus Research, Issue 14, 2022, Page(s) 200240, ISSN 2666-6790 Wydawca: Amsterdam: Elsevier B.V. DOI: 10.1016/j.tvr.2022.200240 Myths and Fake Messages about Human Papillomavirus (HPV) Vaccination: Answers from the ESGO Prevention Committee Autorzy: Nadja Taumberger, Elmar A. Joura, Marc Arbyn, Maria Kyrgiou, Jalid Sehouli, and Murat Gultekin Opublikowane w: International Journal of Gynecological Cancer, Issue 32(10), 2022, Page(s) 1316–20, ISSN 1048-891X Wydawca: Blackwell Publishing Inc. DOI: 10.1136/ijgc-2022-003685 Comparative Effectiveness and Risk of Preterm Birth of Local Treatments for Cervical Intraepithelial Neoplasia and Stage IA1 Cervical Cancer: A Systematic Review and Network Meta-Analysis Autorzy: Antonios Athanasiou, Areti Angeliki Veroniki, Orestis Efthimiou, Ilkka Kalliala, Huseyin Naci, Sarah Bowden, Maria Paraskevaidi, Marc Arbyn, Deirdre Lyons, Pierre Martin-Hirsch, Phillip Bennett, Evangelos Paraskevaidis, Georgia Salanti, and Maria Kyrgiou Opublikowane w: The Lancet. Oncology, Issue 23(8), 2022, Page(s) 1097–1108, ISSN 1470-2045 Wydawca: The Lancet Publishing Group DOI: 10.1016/s1470-2045(22)00334-5 The Impact of HPV Vaccination beyond Cancer Prevention: Effect on Pregnancy Outcomes Autorzy: Susan Yuill, Louiza S. Velentzis, Megan Smith, Sam Egger, C. David Wrede, Deborah Bateson, Marc Arbyn, and Karen Canfell Opublikowane w: Human Vaccines & Immunotherapeutics, Issue 17(10), 2021, Page(s) 3562–76, ISSN 2164-5515 Wydawca: Landes Bioscience DOI: 10.1080/21645515.2021.1936860 A pilot study of risk-stratified cervical cancer screening Autorzy: Jiangrong Wang, K. Miriam Elfström, Christer Borgfeldt, Joakim Dillner Opublikowane w: Open Research Europe, Issue 1, 2021, Page(s) 84, ISSN 2732-5121 Wydawca: EC DOI: 10.12688/openreseurope.13398.1 Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap smear taken - A randomised controlled trial Autorzy: E. Peeters, K. Cornet, D. Devroey, M. Arbyn Opublikowane w: Papillomavirus Research, Issue 9, 2020, Page(s) 100194, ISSN 2405-8521 Wydawca: Elsevier DOI: 10.1016/j.pvr.2020.100194 Cervical Cancer Screening Programs in Latin America: Current Recommendations for Facing Elimination Challenges Autorzy: Ginna Fernández-Deaza, Maria Caicedo-Martínez, Beatriz Serrano, Esther Roura, Juan Sebastián Castillo, Silvia de Sanjosé, Laia Bruni, and Raúl Murillo Opublikowane w: Salud Pública de México, Issue 64(4, jul-ago), 2022, Page(s) 415–23, ISSN 0036-3634 Wydawca: Instituto Nacional de Salud DOI: 10.21149/13204 Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting Autorzy: Anja Oštrbenk Valenčak, Alexander Bertram, Arndt Gröning, Mario Poljak Opublikowane w: Journal of Clinical Virology, Issue 140, 2021, Page(s) 104851, ISSN 1386-6532 Wydawca: Elsevier BV DOI: 10.1016/j.jcv.2021.104851 Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC) Autorzy: Maria Kyrgiou, Marc Arbyn, Christine Bergeron, F. Xavier Bosch, Joakim Dillner, Mark Jit, Jane Kim, Mario Poljak, Pekka Nieminen, Peter Sasieni, Vesna Kesic, Jack Cuzick, Murat Gultekin Opublikowane w: British Journal of Cancer, Issue 123/4, 2020, Page(s) 510-517, ISSN 0007-0920 Wydawca: Nature Publishing Group DOI: 10.1038/s41416-020-0920-9 Metadta: A Stata Command for Meta-Analysis and Meta-Regression of Diagnostic Test Accuracy Data – a Tutorial Autorzy: Victoria Nyawira Nyaga, and Marc Arbyn Opublikowane w: Archives of Public Health, Issue 80, 2022, Page(s) 95, ISSN 2049-3258 Wydawca: London BioMed Central DOI: 10.1186/s13690-021-00747-5 Updated Evidence-Based Recommendations for Cervical Cancer Screening in France Autorzy: Françoise F. Hamers, Anne-Isabelle Poullié, and Marc Arbyn Opublikowane w: European Journal of Cancer Prevention, Issue 31(3), 2022, Page(s) 279–86, ISSN 0959-8278 Wydawca: Lippincott Williams & Wilkins Ltd. DOI: 10.1097/cej.0000000000000701 Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program Autorzy: Ditte Møller Ejegod, Helle Pedersen, Birgitte Tønnes Pedersen, Christine Monceyron Jonassen, Agnes Kathrine Lie, Laila Solhaug Hulleberg, Marc Arbyn, and Jesper Bonde Opublikowane w: American Journal of Clinical Pathology, Issue 157(3), 2021, Page(s) 390–98, ISSN 0002-9173 Wydawca: American Society for Clinical Pathology DOI: 10.1093/ajcp/aqab138 Classification of high‐grade cervical intraepithelial neoplasia by p16 ink4a , Ki‐67, HPV E4 and FAM19A4 / miR124 ‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management Autorzy: Frederique J. Vink, Stèfanie Dick, Daniëlle A. M. Heideman, Lise M. A. De Strooper, Renske D. M. Steenbergen, Birgit I. Lissenberg‐Witte, Arno Floore, Jesper H. Bonde, Anja Oštrbenk Valenčak, Mario Poljak, Karl U. Petry, Peter Hillemanns, Nienke E. Trommel, Johannes Berkhof, Maaike C. G. Bleeker, Chris J. L. M. Meijer Opublikowane w: International Journal of Cancer, Issue 149/3, 2021, Page(s) 707-716, ISSN 0020-7136 Wydawca: John Wiley & Sons Inc. DOI: 10.1002/ijc.33566 National Experience in the First Two Years of Primary Human Papillomavirus (HPV) Cervical Screening in an HPV Vaccinated Population in Australia: Observational Study Autorzy: Megan A Smith., Maddison Sherrah, Farhana Sultana, Philip E. Castle, Marc Arbyn, Dorota Gertig, Michael Caruana, C. David Wrede, Marion Saville, and Karen Canfell Opublikowane w: The BMJ, Issue 376, 2022, Page(s) e068582, ISSN 1756-1833 Wydawca: BMJ DOI: 10.1136/bmj-2021-068582 Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework Autorzy: Sharonjit K. Dhillon, Anja Oštrbenk Valenčak, Lan Xu, Mario Poljak, Marc Arbyn Opublikowane w: Journal of Clinical Microbiology, Issue 59/6, 2021, ISSN 0095-1137 Wydawca: American Society for Microbiology DOI: 10.1128/jcm.00286-21 Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse in HPV-Positive Women with Normal Cytology and Five-Year Type Concordance: A Randomized Comparison Autorzy: Federica Inturrisi, Johannes A. Bogaards, Daniëlle A.M. Heideman, Chris J.L.M. Meijer, Johannes Berkhof Opublikowane w: Cancer Epidemiology Biomarkers & Prevention, Issue 30/3, 2021, Page(s) 485-491, ISSN 1055-9965 Wydawca: American Association for Cancer Research DOI: 10.1158/1055-9965.epi-20-1336 Diagnostic Accuracy of Cervical Cancer Screening Strategies for High-Grade Cervical Intraepithelial Neoplasia (CIN2+/CIN3+) among Women Living with HIV: A Systematic Review and Meta-Analysis Autorzy: Helen Kelly, Iman Jaafar, Michael Chung, Pamela Michelow, Sharon Greene, Howard Strickler, Xianhong Xie, Mark Schiffman, Nathalie Broutet, Philippe Mayaud, Shona Dalal, Marc Arbyn, and Silvia de Sanjosé Opublikowane w: EClinicalMedicine, Issue 53, 2022, Page(s) 101645, ISSN 2589-5370 Wydawca: Oxford: Elsevier DOI: 10.1016/j.eclinm.2022.101645 The confounding effect of multi-type human papillomavirus infections on type-specific natural history parameter identification Autorzy: Anna Suomenrinne-Nordvik, Simopekka Vänskä Opublikowane w: Epidemics, Issue 36, 2021, Page(s) 100468, ISSN 1755-4365 Wydawca: Elsevier BV DOI: 10.1016/j.epidem.2021.100468 Commercially available molecular tests for human papillomaviruses: a global overview Autorzy: M. Poljak, A. Oštrbenk Valenčak, G. Gimpelj Domjanič, L. Xu, M. Arbyn Opublikowane w: Clinical Microbiology and Infection, Issue 26/9, 2020, Page(s) 1144-1150, ISSN 1198-743X Wydawca: Blackwell Publishing Inc. DOI: 10.1016/j.cmi.2020.03.033 Self‐sampling as the Principal Modality for Population Based Cervical Screening: Five‐year Follow‐up of the PaVDaG Study Autorzy: Grazyna A. Stanczuk, Heather Currie, William Forson, Gwendoline Baxter, James Lawrence, Allan Wilson, Timothy Palmer, Marc Arbyn, and Kate Cuschieri. Opublikowane w: International Journal of Cancer, Issue 150(8), 2022, Page(s) 1350–56, ISSN 0020-7136 Wydawca: John Wiley & Sons Inc. DOI: 10.1002/ijc.33888 Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening Autorzy: Caroline Lefeuvre, Hélène De Pauw, Anne-Sophie Le Duc Banaszuk, Adeline Pivert, Alexandra Ducancelle, Franck Rexand-Galais, and Marc Arbyn Opublikowane w: International Journal of Public Health, Issue 67, 2022, Page(s) 1604284, ISSN 1661-8556 Wydawca: Birkhauser Verlag DOI: 10.3389/ijph.2022.1604284 Geographic and Temporal Variations in the Incidence of Vulvar and Vaginal Cancers Autorzy: Freddie Bray, Mathieu Laversanne, Elisabete Weiderpass, and Marc Arbyn Opublikowane w: International Journal of Cancer, Issue 147(10), 2020, Page(s) 2764–71, ISSN 0020-7136 Wydawca: John Wiley & Sons Inc. DOI: 10.1002/ijc.33055 Tackling cervical cancer in Europe amidst the COVID-19 pandemic Autorzy: Marc Arbyn, Laia Bruni, Daniel Kelly, Partha Basu, Mario Poljak, Murat Gultekin, Christine Bergeron, David Ritchie, Elisabete Weiderpass Opublikowane w: The Lancet Public Health, Issue 5/8, 2020, Page(s) e425, ISSN 2468-2667 Wydawca: Elsevier DOI: 10.1016/s2468-2667(20)30122-5 Cervical Cancer Screening Programmes and Age-Specific Coverage Estimates for 202 Countries and Territories Worldwide: A Review and Synthetic Analysis Autorzy: Laia Bruni, Beatriz Serrano, Esther Roura, Laia Alemany, Melanie Cowan, Rolando Herrero, Mario Poljak, Raul Murillo, Nathalie Broutet, Leanne M. Riley, and Silvia de Sanjose Opublikowane w: The Lancet. Global Health, Issue 10(8), 2022, Page(s) e1115–27, ISSN 2214-109X Wydawca: Elsevier BV DOI: 10.1016/s2214-109x(22)00241-8 Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer Autorzy: Federica Inturrisi, Birgit I. Lissenberg‐Witte, Nienke J. Veldhuijzen, Johannes A. Bogaards, Guglielmo Ronco, Chris J. L. M. Meijer, Johannes Berkhof Opublikowane w: International Journal of Cancer, Issue 148/2, 2021, Page(s) 320-328, ISSN 0020-7136 Wydawca: John Wiley & Sons Inc. DOI: 10.1002/ijc.33207 Europe’s Path to Eliminating Cervical Cancer as a Public Health Problem Autorzy: David Ritchie, Marc Arbyn, Partha Basu, Marilys Corbex, Elena Fidarova, Urska Ivanuš, Ginevra Papi, Julie Torode, and Chrysoula Zacharopoulou Opublikowane w: The Lancet Regional Health - Europe, Issue 12, 2021, Page(s) 100276, ISSN 2666-7762 Wydawca: Oxford: Elsevier Ltd. DOI: 10.1016/j.lanepe.2021.100276 Characterization and Diversity of 243 Complete Human Papillomavirus Genomes in Cervical Swabs Using Next Generation Sequencing Autorzy: Ardashel Latsuzbaia, Anke Wienecke-Baldacchino, Jessica Tapp, Marc Arbyn, Irma Karabegović, Zigui Chen, Marc Fischer, Friedrich Mühlschlegel, Steven Weyers, Pascale Pesch, Joël Mossong Opublikowane w: Viruses, Issue 12/12, 2020, Page(s) 1437, ISSN 1999-4915 Wydawca: Multidisciplinary Digital Publishing Institute (MDPI) DOI: 10.3390/v12121437 The European response to the WHO call to eliminate cervical cancer as a public health problem Autorzy: Marc Arbyn, Murat Gultekin, Philippe Morice, Pekka Nieminen, Maggie Cruickshank, Philip Poortmans, Daniel Kelly, Mario Poljak, Christine Bergeron, David Ritchie, Dietmar Schmidt, Maria Kyrgiou, Ann Van den Bruel, Laia Bruni, Partha Basu, Freddie Bray, Elisabete Weiderpass Opublikowane w: International Journal of Cancer, Issue 148/2, 2021, Page(s) 277-284, ISSN 0020-7136 Wydawca: John Wiley & Sons Inc. DOI: 10.1002/ijc.33189 2020 list of human papillomavirus assays suitable for primary cervical cancer screening Autorzy: Marc Arbyn, Marie Simon, Eliana Peeters, Lan Xu, Chris J.L.M. Meijer, Johannes Berkhof, Kate Cuschieri, Jesper Bonde, Anja Ostrbenk Vanlencak, Fang-Hui Zhao, Remila Rezhake, Murat Gultekin, Joakim Dillner, Silvia de Sanjosé, Karen Canfell, Peter Hillemanns, Maribel Almonte, Nicolas Wentzensen, Mario Poljak Opublikowane w: Clinical Microbiology and Infection, Issue 2021 May 8:S1198-743X(21)00219-6., 2021, ISSN 1198-743X Wydawca: Blackwell Publishing Inc. DOI: 10.1016/j.cmi.2021.04.031 Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening Autorzy: Daniëlle A Heideman. M., Anja Oštrbenk Valenčak, Saskia Doorn, Jesper Bonde, Peter Hillemanns, Grega Gimpelj Domjanič, Jana Mlakar, Albertus T. Hesselink, Chris J. L. M. Meijer, and Mario Poljak Opublikowane w: Viruses, Issue 14(5), 2022, Page(s) 893, ISSN 1999-4915 Wydawca: Multidisciplinary Digital Publishing Institute (MDPI) DOI: 10.3390/v14050893 Triage Options to Manage High-Risk Human Papillomavirus-Positive Women: A Population-Based Cross-Sectional Study from Rural China Autorzy: Remila Rezhake, Feng Chen, Shang-Ying Hu, Xue-Lian Zhao, Xun Zhang, Jian Cao, You-Lin Qiao, Fang-Hui Zhao, and Marc Arbyn. Opublikowane w: International Journal of Cancer, Issue 147(8), 2020, Page(s) 2053–64, ISSN 0020-7136 Wydawca: John Wiley & Sons Inc. DOI: 10.1002/ijc.33001 Wyszukiwanie danych OpenAIRE... Podczas wyszukiwania danych OpenAIRE wystąpił błąd Brak wyników
